| Literature DB >> 34678891 |
Lushun Ma1, Xinyuan Pang2, Guofeng Ji1, Xinrui Ma1, Jie Li1, Yuan Chang1, Chong Ma1.
Abstract
BACKGROUND: The neutrophil to lymphocyte ratio (NLR) may be a potential biomarker to evaluate the condition of ulcerative colitis (UC), but whether it can determine the activity of UC is still controversial. So we conducted this meta-analysis to study the relationship between them.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34678891 PMCID: PMC8542122 DOI: 10.1097/MD.0000000000027551
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1The process of study identification.
General characteristics of included studies.
| Number (M/F) | NLR | ||||||||
| Author | Year | Country | UC | HC | UC | Control | Diagnostic criteria of active | Location of UC | Age of patients with UC |
| Torun et al | 2012 | Turkey | 196 (125/71) | 59 (34/25) | 2.67 ± 1.29 | 2.01 ± 0.64 | TWS | R + L + Pan | 43.3 ± 13.5 |
| Celikbilek et al | 2013 | Turkey | 26 (18/8) | 28 (10/18) | 2.79 ± 1.48 | 1.77 ± 0.68 | TWS | – | 44.88 ± 13.23 |
| Xiao et al | 2014 | China | 80 (35/45) | 60 (28/32) | 3.03 ± 1.72 | 1.77 ± 0.66 | TWS | – | 47.14 ± 16.41 |
| Acarturk et al | 2015 | Turkey | 42 (28/14) | 41 (14/27) | 2.84 ± 1.66 | 1.68 ± 0.59 | TWS | – | 39.40 ± 11.15 |
| Demir et al | 2015 | Turkey | 71 (47/24) | 140 (84/56) | 2.31 ± 1.31 | 1.98 ± 0.85 | TWS | – | 46.0 ± 16.7 |
| Jiang et al | 2016 | China | 121 (56/65) | 122 (54/68) | 3.51 ± 2.51 | 1.58 ± 0.73 | Mayo | – | 53.94 ± 15.66 |
| Hanafy et al | 2018 | Egypt | 168 (100/68) | 4.00 ± 2.38 | TWS | L + Pan + P | – | ||
| Okba et al | 2019 | Egypt | 80 (34/46) | 40 (28/12) | 2.13 ± 0.61 | 1.44 ± 0.19 | Mayo | L + Pan + P | 34.0 ± 9.45 |
| Rong et al | 2019 | China | 95 (58/37) | 100 (59/41) | 3.95 ± 1.83 | 1.54 ± 0.75 | Mayo | – | 48.19 ± 6.37 |
| Tian et al | 2019 | China | 148 (91/57) | 42 (20/22) | 2.73 ± 0.39 | 2.10 ± 0.41 | Mayo | L + Pan + P | 48.19 ± 14.77 |
| Xu et al | 2019 | China | 55 (29/26) | 4.94 ± 5.41 | TWS | – | 43.3 ± 9.167 | ||
Assessment of study quality using the Newcastle-Ottawa scale for cohort studies.
| Author | NOS selection | NOS comparability | NOS exposure | Total (max 9) |
| Torun et al | ∗∗∗ | ∗∗ | ∗∗ | 7 |
| Celikbilek et al | ∗∗∗ | ∗∗ | ∗∗ | 7 |
| Xiao et al | ∗∗∗ | ∗∗ | ∗∗∗ | 8 |
| Acarturk et al | ∗∗∗ | ∗∗ | ∗∗ | 7 |
| Demir et al | ∗∗∗ | ∗∗ | ∗∗ | 7 |
| Jiang et al | ∗∗∗ | ∗ | ∗∗ | 6 |
| Hanafy et al | ∗∗∗∗ | ∗∗ | ∗∗ | 8 |
| Okba et al | ∗∗∗ | ∗∗ | ∗∗ | 7 |
| Rong et al | ∗∗∗ | ∗∗ | ∗∗ | 7 |
| Tian et al | ∗∗∗ | ∗∗ | ∗ | 6 |
| Xu et al | ∗∗∗ | ∗∗ | ∗∗∗ | 8 |
Figure 2Meta-analysis of NLR ratio between UC patients and control group. NLR = neutrophil to lymphocyte ratio, SMD = standard mean difference, UC = ulcerative colitis.
Figure 3Subgroup analysis of NLR ratio between UC patients and control group. NLR = neutrophil to lymphocyte ratio, SMD = standard mean difference, UC = ulcerative colitis.
Figure 4Meta-analysis of NLR in active UC group and inactive UC group. NLR = neutrophil to lymphocyte ratio, SMD = standard mean difference, UC = ulcerative colitis.
Figure 5Subgroup analysis of NLR in active UC group and inactive UC group. NLR = neutrophil to lymphocyte ratio, SMD = standard mean difference, UC = ulcerative colitis.